Apollon Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623K | Sell |
3,864
-392
| -9% | -$63.2K | 0.01% | 713 |
|
|
2025
Q1 | $724K | Buy |
4,256
+32
| +0.8% | +$5.44K | 0.02% | 606 |
|
|
2024
Q4 | $702K | Buy |
4,224
+1,371
| +48% | +$228K | 0.02% | 627 |
|
|
2024
Q3 | $491K | Sell |
2,853
-989
| -26% | -$170K | 0.01% | 732 |
|
|
2024
Q2 | $592K | Sell |
3,842
-13
| -0.3% | -$2K | 0.02% | 618 |
|
|
2024
Q1 | $593K | Buy |
3,855
+1,465
| +61% | +$225K | 0.02% | 636 |
|
|
2023
Q4 | $378K | Sell |
2,390
-79
| -3% | -$12.5K | 0.01% | 756 |
|
|
2023
Q3 | $361K | Sell |
2,469
-327
| -12% | -$47.9K | 0.02% | 639 |
|
|
2023
Q2 | $428K | Buy |
2,796
+385
| +16% | +$59K | 0.02% | 643 |
|
|
2023
Q1 | $374K | Sell |
2,411
-15
| -0.6% | -$2.33K | 0.02% | 614 |
|
|
2022
Q4 | $374K | Sell |
2,426
-25
| -1% | -$3.85K | 0.03% | 598 |
|
|
2022
Q3 | $323K | Sell |
2,451
-196
| -7% | -$25.8K | 0.03% | 573 |
|
|
2022
Q2 | $359K | Sell |
2,647
-100
| -4% | -$13.6K | 0.03% | 516 |
|
|
2022
Q1 | $410K | Sell |
2,747
-1,489
| -35% | -$222K | 0.03% | 513 |
|
|
2021
Q4 | $686K | Buy |
+4,236
| New | +$686K | 0.05% | 389 |
|